1. |
Ohta K, Shigemoto K, Fujinami A, et al. Clinical and experimental features of MuSK antibody positive MG in Japan. Eur J Neurol, 2007, 14(9): 1029-1034.
|
2. |
Pasnoor M, Wolfe GI, Nations S, et al. Clinical findings in MuSk-antibody positive myasthenia gravis: a U.S. experience. Muscle Nerve, 2010, 41(3): 370-374.
|
3. |
Guptill JT, Sanders DB, Evoli A. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts. Muscle Nerve, 2011, 44(1): 36-40.
|
4. |
Witoonpanich R, Dejthevaporn C, Pulkes T, et al. Prevalence, clinical features and treatment outcomes of patients with myasthenia gravis positive for antibodies to muscle-specific kinase in Thailand. J Clin Neurosci, 2013, 20(5): 707-709.
|
5. |
Hoch W, McConville J, Helms S, et al. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med, 2001, 7(3): 365-368.
|
6. |
Suhail H, Vivekanandhan S, Singh S, et al. Coexistent of muscle specific tyrosine kinase and acetylcholine receptor antibodies in a myasthenia gravis patient. Neurol India, 2010, 58(4): 668-669.
|
7. |
Poulas K, Koutsouraki E, Kordas G, et al. Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine. J Neuroimmunol, 2012, 250(1/2): 94-98.
|
8. |
Zouvelou V, Zisimopoulou P, Psimenou E, et al. AChR-myasthenia gravis switching to double-seropositive several years after the onset. J Neuroimmunol, 2014, 267(1-2): 111-112.
|
9. |
Ohta K, Shigemoto K, Kubo S, et al. MuSK Ab described in seropositive MG sera found to be Ab to alkaline phosphatase. Neurology, 2005, 65(12): 1988.
|
10. |
Tsonis AI, Zisimopoulou P, Lazaridis K, et al. MuSK autoantibodies in myasthenia gravis detected by cell based assay: a multinational study. J Neuroimmunol, 2015, 284: 10-17.
|
11. |
Evoli A, Tonali PA, Padua L, et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain, 2003, 126(Pt 10): 2304-2311.
|
12. |
Rajakulendran S, Viegas S, Spillane J, et al. Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies. J Neurol, 2012, 259(12): 2736-2739.
|
13. |
Saleh A Al, Cariga P. Myasthenia gravis with AChR and MuSK antibodies positivity: case report. Clin Neurophysiol, 2007, 118(5): e165-e167.
|
14. |
Diaz-Manera J, Rojas-García R, Gallardo E, et al. Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan’s syndrome. Nat Clin Pract Neurol, 2007, 3(7): 405-410.
|
15. |
Saulat B, Maertens P, Hamilton WJ, et al. Anti-muSK antibody after thymectomy in a previously seropositive myasthenic child. Neurology, 2007, 69(8): 803-804.
|
16. |
Sanders DB, Juel VC. MuSK-antibody positive myasthenia gravis: questions from the clinic. J Neuroimmunol, 2008, 201-202: 85-89.
|
17. |
Kostera-Pruszczyk A, Kwiecinski H. Juvenile seropositive myasthenia gravis with anti-MuSK antibody after thymectomy. J Neurol, 2009, 256(10): 1780-1781.
|
18. |
Zouvelou V, Kyriazi S, Rentzos M, et al. Double-seropositive myasthenia gravis. Muscle Nerve, 2013, 47(3): 465-466.
|
19. |
崔伟. 乙酰胆碱受体抗体及肌肉特异性受体酪氨酸激酶抗体均阳性的重症肌无力 1 例报告. 临床神经病学杂志, 2015, 28(4): 258, 261.
|
20. |
Skjei KL, Lennon VA, Kuntz NL. Muscle specific kinase autoimmune myasthenia gravis in children: a case series. Neuromuscul Disord, 2013, 23(11): 874-882.
|
21. |
Jaretzki A 3rd, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis: recommendations for clinical research standards. Task force of the medical scientific advisory board of the myasthenia gravis foundation of America. Neurology, 2000, 55(1): 16-23.
|
22. |
Lebrun C, Bourg V, Tieulie N, et al. Successful treatment of refractory generalized myasthenia gravis with rituximab. Eur J Neurol, 2009, 16(2): 246-250.
|